Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jun 6;26(6):1399-1400.
doi: 10.1016/j.ymthe.2018.05.008. Epub 2018 May 18.

Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer

Affiliations
Comment

Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer

Ion Cristóbal et al. Mol Ther. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Zhu Y., Wang C., Becker S.A., Hurst K., Nogueira L.M., Findlay V.J., Camp E.R. miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer. Mol. Ther. 2018;26:744–754. - PMC - PubMed
    1. Drebber U., Lay M., Wedemeyer I., Vallböhmer D., Bollschweiler E., Brabender J., Mönig S.P., Hölscher A.H., Dienes H.P., Odenthal M. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int. J. Oncol. 2011;39:409–415. - PubMed
    1. Mezencev R., Matyunina L.V., Jabbari N., McDonald J.F. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity. BMC Cancer. 2016;16:236. - PMC - PubMed
    1. Kent O.A., Fox-Talbot K., Halushka M.K. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene. 2013;32:2576–2585. - PMC - PubMed
    1. Yang P., Yang Y., An W., Xu J., Zhang G., Jie J., Zhang Q. The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway. J. Gastroenterol. Hepatol. 2017;32:837–845. - PubMed